ROI Publication Award
The ROI Publication Award recognizes the best scientific work by an early career investigator in one of the priority areas for radiation oncology that form the ROI’s research agenda: communication, safety and quality, toxicity management, comparative effectiveness and value. Using either qualitative or quantitative techniques, articles may present, analyze and comment on new data, or may synthesize and analyze data that have already been collected.
The 2020 ROI Publication Award Winner is Robert T. Dess, MD, of the University of Michigan who is the lead author of the article, "Association of Presalvage Radiotherapy PSA Levels After Prostatectomy with Outcomes of Long-term Antiandrogen Therapy in Men with Prostate Cancer,” which was published in JAMA Oncology. Dr. Dess will use the $5,000 grant that accompanies the ROI Publication Award to continue developing improved prognostic and predictive biomarkers and models in localized and recurrent prostate cancer.
The ROI also selected two early career researchers to recognize with Honorable Mentions: Rachel B. Jimenez, MD, of the Massachusetts General Hospital and lead author of, “Phase II Study of Proton Beam Radiation Therapy for Patients with Breast Cancer Requiring Regional Nodal Irradiation,” which was published in the Journal of Clinical Oncology; and Jacob Miller, MD, of Stanford University School of Medicine and lead author of, “Cost-Effectiveness and Quality-Adjusted Survival of Watch and Wait After Complete Response to Chemoradiotherapy for Rectal Cancer,” which was published in the Journal of the National Cancer Institute. Learn more about these outstanding early career investigators and their research.
Eligibility and Criteria
- An article or a collection of articles resulting from a single study in one of the ROI’s priority research areas are eligible for the award.
- Special consideration will be given to articles that produce new insights and have the potential to change current thinking.
- Articles must have been published in a peer-reviewed journal with a publication date between July 1, 2019, and June 30, 2020, even if it is actually printed at a later date.
- The lead author of the article receives the award and must be a resident, fellow or within 10 years of completing their terminal training program.
- Articles will be scored on importance of key issue/focus, advancement of knowledge in the field and new insights.
How to Apply
- The call for nominations for the 2021 ROI Publication Award will open in the spring.
- Nominations must include a copy of the article(s).
- Nominators must be a member of the American Society for Radiation Oncology (ASTRO). Self-nominations are accepted.
- A brief statement (up to one page) supporting the nomination is required. Be sure to:
- Emphasize how the research published in the manuscript aligns with the ROI’s research agenda and one or more of the priority areas for radiation oncology: communication, safety and quality, toxicity management, comparative effectiveness and value.
- Describe the impact that the research findings will have on the field of radiation oncology as a whole.
- Explain how the $5,000 award would be used to advance the lead author’s current research that builds upon the work in the nominated manuscript.
- Each manuscript will be evaluated by at least two qualified ROI reviewers and then considered by the ROI Research Committee and the ROI Board of Trustees to determine the Award Winner and Honorable Mentions.
- No individual who is an author on a manuscript submitted for consideration may participate in the selection process for determining the ROI Publication Award.
- Manuscripts from the same institution or organization will not be evaluated by members of the ROI Board of Trustees or the ROI Research Committee from that institution or organization.
The ROI launched the Publication Awards program in 2017. Read more about the ROI's inaugural Publication Awards; the 2018 winner, Amar U. Kishan, MD; and the 2019 winner, David Palma, MD, PhD.